Skip to main content

Early Use of Statin in Patients Treated with Alteplase for Acute Ischemic Stroke

  • Chapter

Part of the book series: Acta Neurochirurgica Supplement ((NEUROCHIRURGICA,volume 121))

Abstract

Studies have reported that statin usage before stroke can increase the incidence of intracerebral hemorrhage after thrombolytic treatment. However, whether the administration of statin at an early stage of ischemic stroke increases hemorrhage occurrence is unknown. The aim of this study was to assess the effect of statin on neurological imaging and functional outcomes after intravenous alteplase treatment, within 24 h of acute ischemic stroke attack. A total of 119 consecutive acute ischemic stroke patients treated by intravenous alteplase were recruited, of which 71 patients (59.7 %) were given statin therapy within 24 h of stroke onset. The physiological parameters, including demography, vascular risk factors, and clinical characteristics were recorded. The occurrence of intracerebral hemorrhage (ICH), symptomatic intracerebral hemorrhage (sICH), 90-day functional outcomes, and mortality in the patients were further analyzed. There were 24 occurrences of ICH after alteplase treatment (20.2 %) and there was no difference when patients were treated with statin (p = 0.280). Multivariate logistic regression analysis showed no significant correlation between the administration of statin and the occurrence of ICH (p = 0.230) or sICH (p = 0.949). There was a trend toward better neurological function with higher statin dose. The use of statin in the early stage of ischemic stroke is safe and does not increase the risk of intracerebral hemorrhage after alteplase treatment, suggesting that a clinical trial of early statin treatment on a large scale following thrombolysis is needed for further evaluation.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355(6):549–559

    Article  CAS  PubMed  Google Scholar 

  2. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M (2003) Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53(6):743–751

    Article  CAS  PubMed  Google Scholar 

  3. Prinz V, Laufs U, Gertz K, Kronenberg G, Balkaya M, Leithner C, Lindauer U, Endres M (2008) Intravenous rosuvastatin for acute stroke treatment: an animal study. Stroke 39(2):433–438

    Article  CAS  PubMed  Google Scholar 

  4. Biffi A, Devan WJ, Anderson CD, Cortellini L, Furie KL, Rosand J, Rost NS (2011) Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis. Stroke 42(5):1314–1319

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Chen PS, Cheng CL, Kao Yang YH, Yeh PS, Li YH (2014) Impact of early statin therapy in patients with ischemic stroke or transient ischemic attack. Acta Neurol Scand 129(1):41–48

    Article  CAS  PubMed  Google Scholar 

  6. Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, Hennerici M, MacLeod MJ, Sillesen H, Zweifler R, Michael K, Welch A, Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators (2009) Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 40(11):3526–3531

    Article  CAS  PubMed  Google Scholar 

  7. Cougo-Pinto PT, Santos BL, Dias FA, Fabio SR, Werneck IV, Camilo MR, Abud DG, Leite JP, Pontes-Neto OM (2012) Frequency and predictors of symptomatic intracranial hemorrhage after intravenous thrombolysis for acute ischemic stroke in a Brazilian public hospital. Clinics (Sao Paulo) 67(7):739–743

    Article  Google Scholar 

  8. Engelter ST, Soinne L, Ringleb P, Sarikaya H, Bordet R, Berrouschot J, Odier C, Arnold M, Ford GA, Pezzini A, Zini A, Rantanen K, Rocco A, Bonati LH, Kellert L, Strbian D, Stoll A, Meier N, Michel P, Baumgartner RW, Leys D, Tatlisumak T, Lyrer PA (2011) IV thrombolysis and statins. Neurology 77(9):888–895

    Article  CAS  PubMed  Google Scholar 

  9. Martinez-Ramirez S, Delgado-Mederos R, Marin R, Suarez-Calvet M, Sainz MP, Alejaldre A, Vidal-Jordana A, Marti-Vilalta JL, Marti-Fabregas J (2012) Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis. J Neurol 259(1):111–118

    Article  CAS  PubMed  Google Scholar 

  10. Meseguer E, Mazighi M, Lapergue B, Labreuche J, Sirimarco G, Gonzalez-Valcarcel J, Lavallee PC, Cabrejo L, Guidoux C, Klein IF, Olivot JM, Rouchaud A, Desilles JP, Amarenco P (2012) Outcomes after thrombolysis in AIS according to prior statin use: a registry and review. Neurology 79(17):1817–1823

    Article  PubMed  Google Scholar 

  11. Rocco A, Sykora M, Ringleb P, Diedler J (2012) Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke. Cerebrovasc Dis 33(4):362–368

    Article  CAS  PubMed  Google Scholar 

  12. Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, Luijckx GJ, De Keyser J (2008) Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. J Neurol 255(6):875–880

    Article  CAS  PubMed  Google Scholar 

  13. Alvarez-Sabin J, Huertas R, Quintana M, Rubiera M, Delgado P, Ribo M, Molina CA, Montaner J (2007) Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 38(3):1076–1078

    Article  CAS  PubMed  Google Scholar 

  14. Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ (2010) Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke. Cerebrovasc Dis 29(3):263–267

    Article  CAS  PubMed  Google Scholar 

  15. Cappellari M, Bovi P, Moretto G, Zini A, Nencini P, Sessa M, Furlan M, Pezzini A, Orlandi G, Paciaroni M, Tassinari T, Procaccianti G, Di Lazzaro V, Bettoni L, Gandolfo C, Silvestrelli G, Rasura M, Martini G, Melis M, Calloni MV, Chiodo-Grandi F, Beretta S, Guarino M, Altavista MC, Marcheselli S, Galletti G, Adobbati L, Del Sette M, Mancini A, Orrico D, Monaco S, Cavallini A, Sciolla R, Federico F, Scoditti U, Brusaferri F, Grassa C, Specchio L, Bongioanni MR, Sparaco M, Zampolini M, Greco G, Colombo R, Passarella B, Adami A, Consoli D, Toni D (2013) The THRombolysis and STatins (THRaST) study. Neurology 80(7):655–661

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Cappellari M, Deluca C, Tinazzi M, Tomelleri G, Carletti M, Fiaschi A, Bovi P, Moretto G (2011) Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study. J Neurol Sci 308(1–2):128–134

    Article  CAS  PubMed  Google Scholar 

  17. Ni Chroinin D, Asplund K, Asberg S, Callaly E, Cuadrado-Godia E, Diez-Tejedor E, Di Napoli M, Engelter ST, Furie KL, Giannopoulos S, Gotto AM Jr, Hannon N, Jonsson F, Kapral MK, Marti-Fabregas J, Martinez-Sanchez P, Milionis HJ, Montaner J, Muscari A, Pikija S, Probstfield J, Rost NS, Thrift AG, Vemmos K, Kelly PJ (2013) Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke 44(2):448–456

    Article  CAS  PubMed  Google Scholar 

  18. Scheitz JF, Seiffge DJ, Tutuncu S, Gensicke H, Audebert HJ, Bonati LH, Fiebach JB, Tranka C, Lyrer PA, Endres M, Engelter ST, Nolte CH (2014) Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke. Stroke 45(2):509–514

    Article  CAS  PubMed  Google Scholar 

  19. Dowlatshahi D, Demchuk AM, Fang J, Kapral MK, Sharma M, Smith EE, Registry of the Canadian Stroke Network (2012) Association of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhage. Stroke 43(6):1518–1523

    Article  CAS  PubMed  Google Scholar 

  20. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352(9136):1245–1251

    Article  CAS  PubMed  Google Scholar 

  21. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, Investigators E (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329

    Article  CAS  PubMed  Google Scholar 

  22. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870

    Article  CAS  PubMed  Google Scholar 

  23. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF, American Heart Association/American Stroke Association Stroke Council, American Heart Association/American Stroke Association Clinical Cardiology Council, American Heart Association/American Stroke Association Cardiovascular Radiology and Intervention Council, Atherosclerotic Peripheral Vascular Disease Working Group, Quality of Care Outcomes in Research Interdisciplinary Working Group (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115(20):e478–e534

    Article  PubMed  Google Scholar 

  24. Patkar AA, Hill K, Batra V, Vergare MJ, Leone FT (2003) A comparison of smoking habits among medical and nursing students. Chest 124(4):1415–1420

    Article  PubMed  Google Scholar 

  25. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35–41

    Article  PubMed  Google Scholar 

  26. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19(5):604–607

    Article  PubMed  Google Scholar 

  27. Elkind MS, Flint AC, Sciacca RR, Sacco RL (2005) Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 65(2):253–258

    Article  CAS  PubMed  Google Scholar 

  28. Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC (1999) The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 281(1):53–60

    Article  CAS  PubMed  Google Scholar 

  29. Wang S, Lee SR, Guo SZ, Kim WJ, Montaner J, Wang X, Lo EH (2006) Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes. Stroke 37(7):1910–1912

    Article  CAS  PubMed  Google Scholar 

  30. Zhang L, Zhang ZG, Ding GL, Jiang Q, Liu X, Meng H, Hozeska A, Zhang C, Li L, Morris D, Zhang RL, Lu M, Chopp M (2005) Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation 112(22):3486–3494

    Article  CAS  PubMed  Google Scholar 

  31. Owens AP 3rd, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, Williams JC, Hubbard BK, Dutton JA, Wang J, Tobias PS, Curtiss LK, Daugherty A, Kirchhofer D, Luyendyk JP, Moriarty PM, Nagarajan S, Furie BC, Furie B, Johns DG, Temel RE, Mackman N (2012) Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest 122(2):558–568

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Laumen H, Skurk T, Hauner H (2008) The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes. Atherosclerosis 196(2):565–573

    Article  CAS  PubMed  Google Scholar 

  33. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1587

    Article  Google Scholar 

  34. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, Butman JA, Patronas N, Alger JR, Latour LL, Luby ML, Baird AE, Leary MC, Tremwel M, Ovbiagele B, Fredieu A, Suzuki S, Villablanca JP, Davis S, Dunn B, Todd JW, Ezzeddine MA, Haymore J, Lynch JK, Davis L, Warach S (2004) Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292(15):1823–1830

    Article  CAS  PubMed  Google Scholar 

  35. Neumann-Haefelin T, Hoelig S, Berkefeld J, Fiehler J, Gass A, Humpich M, Kastrup A, Kucinski T, Lecei O, Liebeskind DS, Rother J, Rosso C, Samson Y, Saver JL, Yan B, Group MRS (2006) Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 37(10):2463–2466

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Yanping Song for assistance with statistical analysis. We also thank Xiaoyan Chen for her editorial assistance with the manuscript.

Conflict of Interest

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Guo-Yuan Yang or Yansheng Li .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Geng, J. et al. (2016). Early Use of Statin in Patients Treated with Alteplase for Acute Ischemic Stroke. In: Applegate, R., Chen, G., Feng, H., Zhang, J. (eds) Brain Edema XVI. Acta Neurochirurgica Supplement, vol 121. Springer, Cham. https://doi.org/10.1007/978-3-319-18497-5_47

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18497-5_47

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18496-8

  • Online ISBN: 978-3-319-18497-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics